Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Planche, T.
Right arrow Articles by Krishna, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Planche, T.
Right arrow Articles by Krishna, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2002; 95: 89-97
© 2002 Association of Physicians

Plasma glutamine and glutamate concentrations in Gabonese children with Plasmodium falciparum infection

T. Planche1, A. Dzeing2, A.C. Emmerson1, M. Onanga2, P.G. Kremsner3,4, K. Engel4, M. Kombila2, E. Ngou-Milama5 and S. Krishna1,

1 From the Department of Infectious Diseases, St George's Hospital Medical School, Cranmer Terrace, London, UK, 2 Département de Parasitologie, Mycologie et Médecine Tropicale and 5 Départment de Biochimie, Faculté de Médecine et des Sciences de la Santé, Libreville, Gabon, 3 Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon, 4 Sektion Humanparasitologie, Institut für Tropenmedizin, Universitaet Tübingen, Tübingen, Germany

Received 18 September 2001 and in revised form 31 October 2001

Background: Low plasma glutamine levels in critical illness, neonates and burns patients are associated with poor outcome and increased risk of intercurrent infection.

Aim: To investigate the relationship between plasma glutamine/glutamate levels and severity/outcome of malaria.

Design: Two-hospital prospective study, with both febrile and healthy controls.

Methods: We measured plasma glutamine and glutamate concentrations in 239 Gabonese patients: 145 children with malaria (86 with severe, 36 with moderate and 23 with uncomplicated disease), 42 healthy children, 44 febrile controls and eight healthy adults, and related findings to conventional markers of disease severity such as plasma lactate.

Results: Median (IQR) plasma glutamine was lower in uncomplicated falciparum malaria and in moderate malaria than in healthy controls: 353 (287–474) and 379 (293–448) vs. 485 (428–531) µmol/l, respectively; p<0.01 for both malaria groups vs. controls. In contrast, plasma glutamine was within the normal range in those with severe malaria and in febrile control children: 431 (342–525) and 472 (338–547) µmol/l, respectively. Furthermore, plasma glutamine was significantly higher in the children who died with malaria than in survivors: 514 (374–813) (n=12) vs. 399 (316–475) µmol/l (n=133), respectively; p=0.001. There were no significant differences in plasma glutamate concentrations between any of the study groups.

Discussion: In severe malaria, there was a positive correlation between plasma glutamine and lactate levels (p=0.009, r=0.281). This correlation may reflect impaired gluconeogenesis. Glutamine supplementation is probably not justified in severe P. falciparum infection.

Address correspondence to Professor S. Krishna, Department of Infectious Diseases, St George's Hospital Medical School, Cranmer Terrace, London SW17 ORE. e-mail: s.krishna{at}sghms.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.